{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:57:33Z","timestamp":1762865853908},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.urology.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T23:58:38Z","timestamp":1311465518000},"page":"620-625","source":"Crossref","is-referenced-by-count":10,"title":["Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study"],"prefix":"10.1016","volume":"78","author":[{"given":"A.","family":"Tryakin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fedyanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Kanagavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fainstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sergeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Polockij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Matveev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tjulandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.05.005_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib2","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/cncr.11271","article-title":"Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial","volume":"97","author":"Hinton","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2011.05.005_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1991.9.7.1163","article-title":"Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol","volume":"9","author":"Nichols","year":"1991","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.urology.2011.05.005_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1200\/JCO.2007.13.8461","volume":"26","author":"Culine","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.1998.16.2.692","volume":"16","author":"Kaye","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib6","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1200\/jco.2004.22.14_suppl.4748","article-title":"C-BOP-3BEP as induction chemotherapy (CT) in nonseminomatous germ cell tumor (NSGCT) patients with poor prognosis","volume":"22","author":"Tryakin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib7","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1200\/jco.2010.28.15_suppl.4512","volume":"28","author":"Daugaard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.eururo.2006.10.035","article-title":"Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial","volume":"51","author":"Droz","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.05.005_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.annonc.a010473","article-title":"Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer","volume":"7","author":"Bokemeyer","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib11","first-page":"1537","article-title":"Paclitaxel, ifosfamide, and cisplatin (TIP): an effective second-line therapy for patients (pts) with relapsed testicular germ cell tumors (GCT)","volume":"22","author":"Donadio","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib12","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","article-title":"Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors","volume":"23","author":"Kondagunta","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.bjc.6602682","article-title":"A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a Medical Research Council trial","volume":"93","author":"Mead","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2011.05.005_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<831::AID-IJC24>3.0.CO;2-O","article-title":"Management of intermediate-prognosis germ-cell cancer: results of a phase I\/II study of taxol-BEP","volume":"83","author":"de Wit","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2011.05.005_bib15","unstructured":"Clinicaltrials.gov. Combination chemotherapy in treating men with germ cell cancer (NCT00003643); 2010. Available from: http:\/\/Clinicaltrials.gov\/ct2\/show\/NCT00003643?term=paclitaxel&cond=germ-cell&intr=BEP&rank=1. Accessed 3 May 2011."},{"key":"10.1016\/j.urology.2011.05.005_bib16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6600272","article-title":"Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours","volume":"86","author":"Fizazi","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2011.05.005_bib17","first-page":"240","article-title":"Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study","volume":"54","author":"Mardiak","year":"2007","journal-title":"Neoplasma"},{"key":"10.1016\/j.urology.2011.05.005_bib18","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1200\/jco.2007.25.18_suppl.5087","article-title":"Chemotherapy for poor prognosis nonseminomatous germ cell tumors (NSGCT): should doses be reduced at first cycle to prevent acute respiratory distress syndrome (ARDS) in patients with multiple lung metastases?","volume":"25","author":"Fizazi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib19","first-page":"790","article-title":"Extremely high level of tumor markers do not worsen outcome of nonseminomatous germ cell tumors (NSGCT) patients with poor prognosis (abstract)","volume":"1","author":"Tryakin","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2011.05.005_bib20","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1200\/jco.2011.29.15_suppl.4509","article-title":"A randomized phase III study comparing paclitaxel-BEP (T-BEP) to standard BEP in patients with in intermediate prognosis germ cell cancer (GCC): An intergroup study of EORTC, German TCSG\/AUO, MRC, and Spanish GCC group (EORTC 30983)","volume":"29","author":"De Wit","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511004948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511004948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:19:45Z","timestamp":1592752785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511004948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0090429511004948"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.05.005","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}